These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 20413846)

  • 1. Mitochondrial pathobiology in Parkinson's disease and amyotrophic lateral sclerosis.
    Martin LJ
    J Alzheimers Dis; 2010; 20 Suppl 2():S335-56. PubMed ID: 20413846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases.
    Martin LJ
    Pharmaceuticals (Basel); 2010; 3(4):839-915. PubMed ID: 21258649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial pathobiology in ALS.
    Martin LJ
    J Bioenerg Biomembr; 2011 Dec; 43(6):569-79. PubMed ID: 22083126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biology of mitochondria in neurodegenerative diseases.
    Martin LJ
    Prog Mol Biol Transl Sci; 2012; 107():355-415. PubMed ID: 22482456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondriopathy in Parkinson disease and amyotrophic lateral sclerosis.
    Martin LJ
    J Neuropathol Exp Neurol; 2006 Dec; 65(12):1103-10. PubMed ID: 17146283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a pathogenic role for mitochondria in Parkinson's disease?
    Vives-Bauza C; de Vries RL; Tocilescu MA; Przedborski S
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S241-4. PubMed ID: 20083000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria and neurodegeneration.
    Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
    Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial dysfunction is a converging point of multiple pathological pathways in amyotrophic lateral sclerosis.
    Shi P; Wei Y; Zhang J; Gal J; Zhu H
    J Alzheimers Dis; 2010; 20 Suppl 2():S311-24. PubMed ID: 20463400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial degeneration in amyotrophic lateral sclerosis.
    Xu Z; Jung C; Higgins C; Levine J; Kong J
    J Bioenerg Biomembr; 2004 Aug; 36(4):395-9. PubMed ID: 15377878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mitochondrial permeability transition pore: a molecular target for amyotrophic lateral sclerosis therapy.
    Martin LJ
    Biochim Biophys Acta; 2010 Jan; 1802(1):186-97. PubMed ID: 19651206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage.
    Flønes IH; Fernandez-Vizarra E; Lykouri M; Brakedal B; Skeie GO; Miletic H; Lilleng PK; Alves G; Tysnes OB; Haugarvoll K; Dölle C; Zeviani M; Tzoulis C
    Acta Neuropathol; 2018 Mar; 135(3):409-425. PubMed ID: 29270838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial diseases of the brain.
    Chaturvedi RK; Flint Beal M
    Free Radic Biol Med; 2013 Oct; 63():1-29. PubMed ID: 23567191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.
    Alqahtani T; Deore SL; Kide AA; Shende BA; Sharma R; Dadarao Chakole R; Nemade LS; Kishor Kale N; Borah S; Shrikant Deokar S; Behera A; Dhawal Bhandari D; Gaikwad N; Kalam Azad A; Ghosh A
    Mitochondrion; 2023 Jul; 71():83-92. PubMed ID: 37269968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial dysfunction and amyotrophic lateral sclerosis.
    Hervias I; Beal MF; Manfredi G
    Muscle Nerve; 2006 May; 33(5):598-608. PubMed ID: 16372325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease.
    Rocha EM; De Miranda B; Sanders LH
    Neurobiol Dis; 2018 Jan; 109(Pt B):249-257. PubMed ID: 28400134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial importance in Alzheimer's, Huntington's and Parkinson's diseases.
    Correia SC; Santos RX; Perry G; Zhu X; Moreira PI; Smith MA
    Adv Exp Med Biol; 2012; 724():205-21. PubMed ID: 22411245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of mitochondria in amyotrophic lateral sclerosis.
    Swerdlow RH; Parks JK; Pattee G; Parker WD
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Jun; 1(3):185-90. PubMed ID: 11464951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.